Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer
Sponsor: Alife Health
Summary
To evaluate the clinical pregnancy rate (pregnancy defined as fetal heartbeat at 6-8 weeks) with the adjunctive use of the Hera System (Hera System used with traditional morphological grading) with embryos already deemed suitable for transfer compared to trained embryologists using standard morphology criteria alone.
Official title: Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer: A Randomized Controlled Study
Key Details
Gender
FEMALE
Age Range
21 Years - 43 Years
Study Type
INTERVENTIONAL
Enrollment
440
Start Date
2022-06-13
Completion Date
2025-01
Last Updated
2024-04-17
Healthy Volunteers
Yes
Conditions
Interventions
Hera Score
The device uses patient metadata (patient age, day of image capture) and a software algorithm to analyze features of the blastocyst morphology to provide adjunctive information that may predict further development of the embryo to clinical pregnancy after embryo transfer.
Locations (7)
CCRM
Menlo Park, California, United States
Reproductive Science Center
San Ramon, California, United States
IVF Florida Reproductive Associates
Margate, Florida, United States
Center for Reproductive Medicine
Winter Park, Florida, United States
Ovation Fertility
Austin, Texas, United States
Aspire Fertility
San Antonio, Texas, United States
Reproductive Care Center
Sandy City, Utah, United States